Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will announce its first quarter 2012 financial results on Thursday, April 26, 2012 after the financial markets close. The company will host a conference call at 5:00 p.m. EDT.
The conference call will be webcast live and a link to the webcast may be accessed from the â€˜Events & Presentationsâ€™ page of Vertexâ€™s website at www.vrtx.com. A replay of the conference call and webcast will be archived on the companyâ€™s website until May 10, 2012. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, MA, we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and Science magazine named Vertex number one on its 2011 list of Top Employers in the life sciences.
Vertexâ€™s press releases are available at www.vrtx.com.
Last updated on: 10/04/2012